Patents for C12N 5 - Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor (182,629) |
---|
01/22/2009 | CA2693156A1 Differentiation of human embryonic stem cells |
01/22/2009 | CA2693144A1 Methods to identify and enrich for populations of ovarian cancer stem cells and somatic ovarian stem cells and uses thereof |
01/22/2009 | CA2692912A1 An anti-cancer cytotoxic monoclonal antibody |
01/22/2009 | CA2692826A1 An anti-cancer cytotoxic monoclonal antibody |
01/22/2009 | CA2692823A1 An anti-cancer cytotoxic monoclonal antibody |
01/22/2009 | CA2691847A1 Treatments and diagnostics for cancer, inflammatory disorders and autoimmune disorders |
01/21/2009 | EP2017341A2 Apo-2 ligand |
01/21/2009 | EP2017338A1 Muscle-specific expression vectors |
01/21/2009 | EP2017337A1 Human tumor necrosis factor receptors |
01/21/2009 | EP2017335A1 Mutated Abl kinase domains |
01/21/2009 | EP2017333A1 Feline cell capable of being cultured without animal protein, and method for production of virus and method for production of vaccine using the feline cell |
01/21/2009 | EP2017286A2 Transporter genes |
01/21/2009 | EP2016951A1 Polypeptides homologous to VEGF and BMP1 |
01/21/2009 | EP2016930A2 A cell therapy method for the treatment of tumors |
01/21/2009 | EP2016172A1 Diagnostic methods for determining treatment |
01/21/2009 | EP2016171A2 Stem cells derived from bone marrow for tissue regeneration |
01/21/2009 | EP2016170A1 Production and use of regulatory t cells |
01/21/2009 | EP2016099A1 Method for the production of antibodies in immunodeficient animal injected with human fetal liver stem cells |
01/21/2009 | EP2015772A2 Agent for the treatment of malignant diseases |
01/21/2009 | EP2015745A2 Macrocyclic kinase inhibitors |
01/21/2009 | EP1831384A4 Polypeptides having glucoamylase activity and polynucleotides encoding same |
01/21/2009 | EP1585770B1 Recognition molecules for the treatment and detection of tumours |
01/21/2009 | EP1570052B1 Method for culturing neural stem cells using hepatocyte growth factor |
01/21/2009 | EP1569680B1 Treatment of diabetes |
01/21/2009 | EP1511515B1 Stimulation of hematopoiesis by ex vivo activated immune cells |
01/21/2009 | EP1506228B1 Role of p62 in aging-related disease |
01/21/2009 | EP1495330B1 Method of identifying transmembrane protein-interacting compounds |
01/21/2009 | EP1414945B1 Cell culture method for obtaining prostate-like acini |
01/21/2009 | EP1399563B1 Moraxella (branhamella) catarrhalis antigens |
01/21/2009 | EP1261701B1 FULL-LENGTH INFECTIOUS cDNA CLONES OF TICK BORNE FLAVIVIRUS |
01/21/2009 | EP1234880B1 Novel protein tab2 |
01/21/2009 | EP1127107B1 Methods for the production of tcr gamma delta t cells |
01/21/2009 | EP0993468B1 Compositions and methods for activating genes of interest |
01/21/2009 | EP0904276B1 A plant nuclear scaffold attachment region which increases gene expression |
01/21/2009 | EP0850053B1 Erythrocytes loaded with s-nitrosothiol and uses therefor |
01/21/2009 | CN101351557A Gene transfer into airway epithelial stem cell by using lentiviral vector pseudotyped with RNA virus or DNA virus spike protein |
01/21/2009 | CN101351547A PDX1-expressing dorsal and ventral foregut endoderm |
01/21/2009 | CN101351546A Method for treating disseminated cancer |
01/21/2009 | CN101351545A Materials and methods for treating chronic fibrotic disease |
01/21/2009 | CN101351544A Transplantation of glial restricted precursor-derived astrocytes for promotion of axon growth |
01/21/2009 | CN101351475A Interleukin-12p40 variants with improved stability |
01/21/2009 | CN101351230A Implantable biocompatible immunoisolatory vehicle for delivery of GDNF |
01/21/2009 | CN101351229A Therapeutic method for blood coagulation disorder |
01/21/2009 | CN101351221A Outer coat protein PA5158 of pseudomonas aeruginosa |
01/21/2009 | CN101351118A The use of apoptotic cells ex vivo to generate regulatory t cells |
01/21/2009 | CN101348793A Insecticidal proteins from bacillus thuringiensis |
01/21/2009 | CN101348792A Plant-optimized polynucleotides encoding approximately 15 kDa and approximately 45 kda pesticidal proteins |
01/21/2009 | CN101348789A Production of human mutant proteins in human cells by homologous recombination |
01/21/2009 | CN101348785A Regulation of viral gene expression |
01/21/2009 | CN101348780A Method of isolation and purification of trypsin from pronase protease and use thereof |
01/21/2009 | CN101348777A Influenza A virus ELISA nucleoprotein capture antigen diagnose reagent kit and special monoclonal antibody therefor |
01/21/2009 | CN101347458A Sheep X/Y sperm separation freezing sperm as well as preparation method and use thereof |
01/21/2009 | CN101347099A Method for quickly breeding Louisiana cypress in-vitro |
01/21/2009 | CN101347098A Method of propagation of Tilia miqueliana by tissue culture |
01/21/2009 | CN101347097A Method of somatic embryogenesis of cassava and rapid propagation of regenerated plant |
01/21/2009 | CN100453645C Antibodies against insulin-like growth factor i receptor and uses thereof |
01/21/2009 | CN100453640C Method of separating multipotent adult progenitor cells from umbilical cord blood |
01/21/2009 | CN100453639C Chinese yew sprout tissue culture medium and its sprout breeding method |
01/21/2009 | CN100453555C Paddy rice fragile straw controlling gene BC1 and use thereof |
01/21/2009 | CN100452961C Liquid-storing bamboo stem planting process |
01/20/2009 | USRE40624 An isolated nucleic acid encoding the ASKRK polypeptide comprising an amino acid identification sequence #2; nucleotide sequences; expression vector; pancreatic beta host cell. antidiabetic agents; non-insulin dependent diabetes |
01/20/2009 | US7479589 Plants and seeds of corn variety CV553210 |
01/20/2009 | US7479588 Inbred corn line PH7GD |
01/20/2009 | US7479587 Inbred corn line MN5 |
01/20/2009 | US7479584 Methods and compositions for modulating flowering and maturity in plants |
01/20/2009 | US7479583 Soybean variety 4336643 |
01/20/2009 | US7479582 Soybean variety 4671685 |
01/20/2009 | US7479580 Field pea cultivar CDC 0001 |
01/20/2009 | US7479573 Cationic lipids capable of facilitating transport of biologically active agents or substances into cells; lipid aggregate macromolecular complex interacts with cells making the polyanionic macromolecule available for absorption and uptake by the cell |
01/20/2009 | US7479549 Recombinant canine thyroid stimulating hormone and methods of production and use thereof |
01/20/2009 | US7479547 Using shuffled viral protein sequences as tool in generating antibodies for diagnosis, prevention and treatment of viral disease |
01/20/2009 | US7479545 Used as pharmaceuticals, diagnostics, biosensors and bioreactors |
01/20/2009 | US7479543 chimeric antibodies comprising variable domain peptides, DNA codes for the antibodies, expression vectors, host cells and a process of culturing the host cells to produce the monoclonal antibodies, used for immunotherapy; nonimmunogenic |
01/20/2009 | US7479541 and fusion proteins with green fluorescent protein, used for modulating cell differentiation and apoptosis, including cell formation of tissues |
01/20/2009 | US7479539 Hedgehog fusion proteins |
01/20/2009 | US7479530 Comprising one or more macromonomer units selected from perfluoroalkylpolyether, fluorinated poly(meth)acrylate, poly(perfluoroalkyl) (meth)acrylate, poly(fluoroalkyl) (meth)acrylamide, and fluorinated polyolefin, and one or more charged units; intraocular lenses |
01/20/2009 | US7479481 Treatment of ocular diseases and disorders using lantibiotic compositions |
01/20/2009 | US7479478 Human parathyroid hormone modifications, preparation and use |
01/20/2009 | US7479387 Host cell transformed with recombinant enzymes from Arabidopsis thaliana to synthesize 6-sulfo-alpha-D-quinovosyl diaclyglycerol (SQDG) also called sulfoquinovosyldiacylglycerol, KM043 which is a polymerase inhibitor drug; sqdX gene for example |
01/20/2009 | US7479386 Hepatitis X virus for use in generation of antibody and vaccine compositions for use in diagnosis, prevention and treatment viral infection; immunotherapeutic and diagnostics |
01/20/2009 | US7479377 Genetic construct intracellular monitoring system |
01/20/2009 | US7479373 Method for identifying compounds modulating taste transduction |
01/20/2009 | US7479284 Babesia canis vaccine |
01/20/2009 | CA2370330C Biodegradable poly(propylene fumarate) networks cross linked with poly(propylene fumarate)-diacrylate macromers |
01/20/2009 | CA2236263C Methods for use of mpl ligands with primitive human stem cells |
01/20/2009 | CA2137822C Method for detecting pre-cancerous or cancerous cells using p90 antibodies or probes |
01/20/2009 | CA2108473C Heregulins (hrgs) binding proteins of p185erb2 |
01/15/2009 | WO2009009591A2 Use of cells to facilitate targeted delivery of nanoparticle therapies |
01/15/2009 | WO2009009142A2 Transgenic plants with enhanced agronomic traits |
01/15/2009 | WO2009009063A1 Immunotherapy for hematological malignancies |
01/15/2009 | WO2009009020A1 Human disc tissue |
01/15/2009 | WO2009008950A2 Identification of trpml3 (mcoln3) as a salty taste receptor and use in assays for identifying taste (salty) modulators and/or therapeutics that modulate sodium transport, absorption or excretion and/or aldosterone and/or vasopressin production or release |
01/15/2009 | WO2009008928A2 Methods for treating nervous system injury and disease |
01/15/2009 | WO2009008713A1 Tap-inhibitors from old world primate 1-herpesviruses and their use |
01/15/2009 | WO2009008666A2 Autologous dendritic cell mediated by photodynamic therapy having the ability to suppress the growth of tumor |
01/15/2009 | WO2009008547A1 Cell culture substrate |
01/15/2009 | WO2009008529A1 Antibody binding specifically to tdp-43 aggregate |
01/15/2009 | WO2009008511A1 Normal-pressure glaucoma model and method of evaluating test substance by using the same |
01/15/2009 | WO2009008503A1 Process for selective production of theaflavin |
01/15/2009 | WO2009008496A1 Anti-hsulf1 antibody |